| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |